Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
about
Demographics, guidelines, and clinical experience in severe community-acquired pneumoniaIs COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysisThe prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative reviewPrior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired-pneumonia.Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.How do COPD comorbidities affect ICU outcomes?Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.Thin-section CT findings in Pseudomonas aeruginosa pulmonary infection.Non-invasive ventilation in exacerbations of COPD.Risk factors for mortality in patients admitted to intensive care units with pneumonia.Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategiesThe role of complications of community acquired pneumonia on the outcome of the illness: a prospective observational study in a tertiary institution in eastern NigeriaA cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?Mucosal vaccination against bacterial respiratory infections.Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.Five-year mortality in patients treated for severe community-acquired pneumonia - a retrospective study.Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia.COPD patients with ventilator-associated pneumonia: implications for management.Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ.The prognostic value of muscle regional oxygen saturation index in severe community-acquired pneumonia: a prospective observational study.The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.Effect of Anemia on Mortality in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease.Reasons for ICU demand and long-term follow-up of a chronic obstructive pulmonary disease cohort.Morphological prognostic factors in nosocomial pneumonia: an autopsy study.Community-acquired pneumonia and Gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics.Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.Pressure-support ventilation or T-piece spontaneous breathing trials for patients with chronic obstructive pulmonary disease - A randomized controlled trial
P2860
Q21195015-06AA4E0F-DFD6-40CD-B00C-A6111822F1D2Q26801413-643BDB23-F8ED-4211-9C29-9003CAC72BF7Q26825072-4E6E18F7-553E-4F1C-92AD-99194BAD6059Q33790733-5344FB77-C71A-46AD-AD5C-7358D8C1A570Q33919350-0332BECB-873C-4B29-AD74-9C470CF0C873Q34026982-B06C25C0-2EA8-40C8-8F7A-B878B1E2F6DBQ34105094-DBDA72AF-158C-47E4-9B5D-61FFCE2472BDQ34394315-BDBA116F-AD87-47CB-8C6A-445E5344323EQ34462623-3F999B44-1FC6-4BD8-9294-4CEF8275F061Q34492540-F664F66F-539F-409E-82B1-8A194223DA22Q34888769-207EE4A1-FAC2-4AD7-936E-AAE448C8AF35Q35219711-1A81129B-0FCE-43B8-A421-494796415348Q36727089-918C82F4-6300-413B-AA85-2931EC9B8CD1Q37082582-FACA55E4-FE03-4A65-95C5-99190F0A45C6Q37084772-608E27BB-6DD9-4620-A29E-E47EC2E9FA20Q37152982-FB661889-0478-492A-83A9-D46F40C6599EQ37222291-CDE1F237-38E9-401D-A343-5C8170121B81Q37226357-3823F64D-73E6-45D5-9B04-998DCC28E7EFQ37290114-D94CF2D5-087D-4ED5-951A-519B62C78E18Q37870823-B5567212-3E2C-43E2-80C1-C105DF9A1D8DQ38040130-450E5C8E-DA06-49D6-BB38-8023691228A4Q38097887-F3BA40D0-E8E6-44F4-A915-92505417D5B9Q38740312-82A1C048-3CBA-4D62-A2CE-7037A1860460Q38977618-B243E633-3751-44FE-A778-0EB225041E48Q39051283-94EB4044-4A32-4597-86B0-3D99898479C7Q39358377-D121CC4A-3D12-40B7-91D7-0AD7A3EBAAA0Q40500207-CCA2551E-6197-4CFB-8AD8-51DC2CD9DF01Q41389337-0E6181FE-8669-422B-9FEB-FAFC2B2CB1B3Q42134928-6DE5C104-38C4-49B8-AB66-0E6576884B35Q47650827-BDEA0387-1712-4DBD-B677-CF8EF494934CQ47726391-922D12C7-A385-4742-B73D-0EBBB9769BB5Q51717925-B05E122C-1DFB-4E17-9B38-E15978E4A812Q51779301-250CF31E-26E7-4276-B06B-B1BA9159426EQ54248399-94402F54-AD2C-4D64-9232-66ACE2CEB912Q55440444-0C196D0D-B5AA-4054-9ED5-53C6D0C4305AQ58715467-13544ABB-2AC2-4DF6-99C1-931389D1B6C8
P2860
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
description
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2006
@uk
name
Implications of COPD in patien ...... y community-acquired pneumonia
@en
Implications of COPD in patien ...... y community-acquired pneumonia
@nl
type
label
Implications of COPD in patien ...... y community-acquired pneumonia
@en
Implications of COPD in patien ...... y community-acquired pneumonia
@nl
prefLabel
Implications of COPD in patien ...... y community-acquired pneumonia
@en
Implications of COPD in patien ...... y community-acquired pneumonia
@nl
P2093
P50
P921
P1476
Implications of COPD in patien ...... y community-acquired pneumonia
@en
P2093
J M Sirvent
J Sole-Violan
M V de la Torre
P304
P356
10.1183/09031936.06.00139305
P577
2006-03-01T00:00:00Z